Risk Factors for Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer

Shimizu, D; Miyata, K; Fukaya, M; Sugita, S; Ebata, T

Miyata, K (通讯作者),Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, 65 Tsurumai Cho,Showa Ku, Nagoya 4668550, Japan.

ANTICANCER RESEARCH, 2023; 43 (3): 1309

Abstract

Background/Aim: In patients with esophageal cancer, muscle loss induced by neoadjuvant therapy before esophagectomy is correlated with poor prognosis.......

Full Text Link